Las Vegas, NV -- (SBWIRE) -- 10/15/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: L&L Energy, Inc. (NASDAQ:LLEN), Oclaro, Inc. (NASDAQ:OCLR), China BAK Battery Inc. (NASDAQ:CBAK), Generex Biotechnology Corporation (OTCMKTS:GNBT).
L&L Energy, Inc. (NASDAQ:LLEN) managed to keep its fall at -2.91% on traded volume of 2.56 million shares. The stock settled at $3.41 after floating in a range of $1.51 to $1.77. After recent close, it has reached market capitalization of $64.38 million. Its 52-week range has been $0.94 to $4.94. L&L Energy, Inc., through its subsidiaries, engages in production, processing, and sale of coal in the People’s Republic of China. The company operates in three segments: Coal Mining, Coal Wholesaling, and Coking Coal.
Will LLEN Get Buyers Even After The Recent Rally? Find Out Here
Oclaro, Inc. (NASDAQ:OCLR) traded up on a volume of 2.53 million, higher than its standard daily volume. Shares have gained 3.41% to $2.12. Over the last twelve months the stock has lost -4.07% and faced a worst price of $2.02. Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide.
Will OCLR Continue To Move Higher? Find Out Here
China BAK Battery Inc. (NASDAQ:CBAK) settled 9.43% higher at $2.60 on traded volume of 2.38 million shares during the last trading day, while its average trading volume remained 139.090 shares. The stock has its 12-month low at $0.59 and 52-week high price was $3.45. It traded in a range of $2.77 to $3.45 during the last trading day. China BAK Battery, Inc., together with its subsidiaries, engages in the manufacture, commercialization, and distribution of standard and customized lithium ion (Li-ion) rechargeable batteries.
Will CBAK Continue To Move Higher? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) saw its price gain on traded volume as 2.30 million shares changed hands when compared with its average daily volume of 1.76 million shares. The stock was up 0.98% to $0.0308. It has fallen over the last 12 months, dropping -45.96% and marked new low $0.02. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)